申请人:SmithKline Beecham Corporation
公开号:US20020077455A1
公开(公告)日:2002-06-20
The present invention provides compounds which inhibit proteases, including cathepsin K, pharmaceutical compositions of such compounds, and methods for treating diseases of excessive bone loss or cartilage or matrix degradation, including osteoporosis; gingival disease including gingivitis and periodontitis; arthritis, more specifically, osteoarthritis and rheumatoid arthritis; Paget's disease; hypercalcemia of malignancy; and metabolic bone disease, comprising inhibiting said bone loss or excessive cartilage or matrix degradation by administering to a patient in need thereof a compound of the present invention.
本发明提供抑制蛋白酶(包括卡他普星K)的化合物,以及这些化合物的制药组合物和治疗骨质过度流失或软骨或基质降解等疾病的方法,包括骨质疏松症;牙龈疾病,包括牙龈炎和牙周病;关节炎,更具体地说是骨关节炎和类风湿性关节炎;帕吉特病;恶性高钙血症;以及代谢性骨病,通过给需要治疗的患者投与本发明的化合物来抑制这种骨质流失或过度软骨或基质降解。